Cargando…
Complete biologic response to taxane based chemotherapy confirmed by [(18)F]FDG PET/CT and surgery in a cancer of unknown primary site
Cancers of an unknown primary site are heterogenous with respect to their clinical and pathologic features. They are generally very aggressive, but specific favorable subsets have a better prognosis. For these favorable subsets, taxane based chemotherapy is very effective for a subset of woman with...
Autores principales: | Hwang, Jun-Eul, Yoon, Ju-Young, Bae, Woo-Kyun, Shim, Hyun-Jeong, Chung, Ik-Joo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Gynecologic Oncology and Colposcopy
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280069/ https://www.ncbi.nlm.nih.gov/pubmed/22355469 http://dx.doi.org/10.3802/jgo.2012.23.1.65 |
Ejemplares similares
-
The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer
por: Kim, Ka-Rham, et al.
Publicado: (2017) -
Detection of primary sites in unknown primary tumors using FDG-PET or FDG-PET/CT
por: Park, Jong Sun, et al.
Publicado: (2011) -
FDG PET/CT in carcinoma of unknown primary
por: Kwee, Thomas C., et al.
Publicado: (2009) -
Diagnostic Value of (18)F-FDG PET/CT in Patients with Carcinoma of Unknown Primary
por: Cengiz, Arzu, et al.
Publicado: (2018) -
The association of (18)F-FDG PET/CT and biomarkers in confirming coronary microvascular dysfunction
por: Mayala, Henry Anselmo, et al.
Publicado: (2018)